Results 91 to 100 of about 225,397 (165)

Prevalence of Graves ophthalmopathy among patients with thyroid disease

Philippine Journal of Ophthalmology, 2010
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD, Evelyn S. Morabe, MD, Paulo Ma. N. Pagkatipunan, MD   +2 more
doaj  

Increased retinal blood flow in patients with active Graves' ophthalmopathy

, 2007
PURPOSE: To investigate retinal blood flow by Heidelberg retina flowmeter in patients with active Graves' ophthalmopathy. MATERIALS AND METHODS: Thirty patients with active Graves' ophthalmopathy in euthyroid state and thirty normal controls were ...
Costagliola, Ciro, CAMPA, Claudio, INCORVAIA, Carlo, SEBASTIANI, Adolfo, PERRI, Paolo, Costagliola C., D'ANGELO, Sergio   +6 more
core   +1 more source

Graves' ophthalmopathy

Swiss Medical Weekly, 2002
Swiss Medical Weekly
doaj   +1 more source

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Acta Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H., Umar H., Aman A. M., Rasyid H., Bakri S., Iskandar H.   +5 more
doaj   +1 more source

Treatment of ophthalmopathy in the course of Graves’ disease

Journal of Education, Health and Sport, 2019
: Introduction: Graves’ disease is an autoimmune disease in which the TSH receptor (TSHR) is an autoantigen. Its stimulation by antibodies inhibiting thyrotropin binding causes increased secretion of free thyroid hormones and consequently symptoms of ...
Magdalena Woźniak, Ewa Tywanek, Grzegorz Rudzki, Joanna Świrska, Agnieszka Zwolak, Robert Jan Łuczyk   +5 more
doaj  

Immunomodulators in Graves' ophthalmopathy: a systematic review. [PDF]

Front Endocrinol (Lausanne)
Yeung A, Siddiqui MS, Mirtorabi N, Ahmed UN, Watts E, Sharma N, Kumari R, Boelaert K, Muzaffar J, Nieto H.   +9 more
europepmc   +1 more source

Visual Field and Graves Ophthalmopathy

, 2015
Whether primary or secondary to thyroid disease, Graves\u27 ophthalmopathy is surprising by its evolution despite correct treatment. Transformation to acute mode may occur very quickly.
Sabine Defoort-Dhellemmes; Jean-Philippe Woillez; Virginie Rufin
core  

Multiparametric MRI quantitative metrics for grading and staging graves' ophthalmopathy. [PDF]

BMC Med Imaging
Wu S, Yang L, Cai Y, Liang J, Wen J, Huang H, Yu S.   +6 more
europepmc   +1 more source

Epigenetic Modulation of Thyroid-Stimulating Hormone Receptor Expression in Orbital Fibroblasts From Graves' Ophthalmopathy: Target for Treatment. [PDF]

Invest Ophthalmol Vis Sci
Chompoowong R, Phankeaw P, Suwannavong A, Visamol S, Pitikiadtikun S, Saonanon P, Pruksakorn V, Potita P, Palaga T, Virakul S.   +9 more
europepmc   +1 more source

Correction: Extraocular muscle index as a novel indicator of inflammatory condition in graves' ophthalmopathy patients. [PDF]

Front Endocrinol (Lausanne)
Wu F, Huang J, Wang M, Qian Z, Wang Y, Fang W.   +5 more
europepmc   +1 more source